Subscribe to Daily Review - your favourite M&A deals update.

MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Stefan Oelrich
Stefan OelrichBAYER AG

Stefan Oelrich

Board Member and President of the Pharmaceuticals Division at BAYER AG

Manager

Deal Bio

Total Deals4
Valued Deals3
Total Value£ 4.98 B
Avg. Deal Size£ 1.66 B

Market Context

Sort

08 Aug 2019|United States|Biotechnology
Bluerock Therapeutics
Bayer

Target: BLUEROCK THERAPEUTICS

Bidder: BAYER AG

4 Service Providers

1 Target | 2 Bidder | 1 Vendor

21 Dealmakers

2 Target | 16 Bidder | 3 Vendor

£ 493 M

Value

26 Oct 2020|United States|Biotechnology
Asklepios Biopharmaceutical
Bayer

Target: ASKLEPIOS BIOPHARMACEUTICAL INC

Bidder: BAYER AG

10 Service Providers

4 Target | 3 Bidder | 3 Vendor

38 Dealmakers

20 Target | 8 Bidder | 10 Vendor

£ 3.05 B

Value

05 Aug 2021|United States|Biotechnology
Vividion Therapeutics
Bayer

Target: VIVIDION THERAPEUTICS

Bidder: BAYER AG

13 Service Providers

3 Target | 3 Bidder | 7 Vendor

47 Dealmakers

22 Target | 5 Bidder | 21 Vendor

£ 1.44 B

Value

18 Jan 2023|United Kingdom|Medical Services
Blackford Analysis
Bayer

Target: BLACKFORD ANALYSIS LTD

Bidder: BAYER AG

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

1 Target | 2 Bidder

n/a

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite